Expression and functional role of inhibitor-of-apoptosis protein livin (BIRC7) in neuroblastoma

Biochemical and Biophysical Research Communications

Volumn 400, Issue 1, 2010, Pages 53-59

  Dasgupta, Anindya ^a   Alvarado, Carlos S ^a   Xu, Zhiheng ^b   Findley, Harry W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Apoptosis; Drug resistance; Gene silencing; Livin; MYCN; Neuroblastoma

Indexed keywords

DOXORUBICIN; ETOPOSIDE; LIVIN; PACLITAXEL; SMALL INTERFERING RNA; VINCRISTINE; BIRC7 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR PROTEIN;

ADVANCED CANCER; ARTICLE; CANCER RESISTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CHILD; DRUG RESISTANCE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CHILD; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 79952208862     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.001     Document Type: Article

References (29)

1. Lin J.H., Deng G., Huang G., Mosser J. KIAP, a novel member of the inhibitor of apoptosis protein family. Biochem. Biophys. Res. Commun. 2000, 279:820-831.
2. Kasof G.M., Gomes B.C. Livin, a novel inhibitor of apoptosis protein family member. J. Biol. Chem. 2001, 276:3238-3246.
3. Ma L., Huang Y., Song Z., et al. Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ. 2006, 13:2079-2088.
4. Ashhab Y., Alian A., Polliack A., et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 2001, 495:56-60.
5. Crnkovic-Mertens I., Semzow J., Hoppe-Seyler F., Butz K. Isoform-specific silencing of the livin gene by RNA interference defines livin beta as key mediator of apoptosis inhibition in HeLa cells. J. Mol. Med. 2006, 84:232-240.
6. Abd-Elhrahman I., Hersko K., Neuman T., et al. The inhibitor-of-apoptosis protein livin (ML-IAP) plays a dual role in tumorigenicity. Cancer Res. 2009, 69:5475-5480.
7. Vucic D., Stennicke H.R., Pisabarro M.T., et al. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr. Biol. 2000, 10:1359-1366.
8. Gazzaniga P., Gradilone A., Giuliani L., et al. Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer. Ann. Oncol. 2003, 14:85-909.
9. Tanabe H., Yagihashi A., Tsuji N., et al. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer. Lung Cancer 2004, 46:299-304.
10. Gong J., Chen N., Zhou Q., et al. Melanoma inhibitor of apoptosis protein is expressed differently in melanoma, melanocytic naevus but similarly in primary metastatic melanomas. J. Clin. Pathol. 2005, 58:1081-1085.
11. Kempkensteffen C., Hinz S., Christoph F., et al. Expression of the apoptosis inhibitor livin in renal cell carcinoma: correlations with pathology and outcome. Tumour Biol. 2007, 28:132-138.
12. Nedelcu T., Kubista B., Koller A., et al. Livin and Bcl-2 expression in high-grade osteosarcoma. J. Cancer Res. Clin. Oncol. 2008, 134:237-244.
13. Nachmias B., Ashab Y., Bucholtz V., et al. Caspase-mediated cleavage converts livin from antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. Cancer Res. 2003, 63:6340-6349.
14. Kim D.-K., Alvarado C.S., Abramowsky C.R., et al. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome. Pediatr. Dev. Pathol. 2005, 8:621-629.
15. Mousavi-Shafaei P., Ziaee A.A., Azizi E., Zangemeister U. Antisense-mediated melanoma inhibitor of apoptosis protein downregulation sensitizes G361 melanoma cells to cisplatin. Anticancer Drugs 2006, 17:1031-1039.
16. Crnkovic-Mertens I., Hoppe-Seyler F., Butz K. Induction of apoptosis in tumors cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 2003, 22:8330-8336.
17. Berthold F., Simon T. Clinical presentation. Neuroblastoma 2005, 63-85. Springer-Verlag, New York. N.-K.V. Cheung, S.L. Cohn (Eds.).
18. Alvarado C.S., London W.B., Look A.T., et al. Natural history and biology of stage a neuroblastoma: a pediatric oncology group study. J. Pediatr. Hematol. Oncol. 2000, 22:197-205.
19. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: Children's Cancer Group. N. Engl. J. Med. 1999, 341:1165-1173.
20. Maris J.M., Hagarty M.D., Bagatell R., Cohn S.L. Neuroblastoma. The Lancet 2007, 369:2106-2120.
21. Brodeur G.M., Pritchard J., Berthold F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 1993, 111:466-477.
22. Crnkovic-Mertens I., Muley T., Meister M., et al. The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells. Lung Cancer 2006, 54:135-142.
23. Crnkovic-Mertens I., Wagener N., Semzow J., et al. Targeted inhibition of livin resensitizes renal cancer cells towards apoptosis. Cell. Mol. Life Sci. 2007, 64:1137-1144.
24. Wang R., Lin F., Wang X., et al. Silencing livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells. Cancer Gene Ther. 2008, 15:402-412.
25. Seeger R.C., Wada R., Brodeur G.M., et al. Expression of N-Myc by neuroblastomas with one or multiple copies of the oncogene. Prog. Clin. Biol. Res. 1988, 271:41-49.
26. Fulda S., Lutz W., Schwab M., Debatin K.M. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene 1999, 18:1479-1486.
27. Dasgupta A., Pierce S.K., Findley H.W. MycN is a transcriptional regulator of livin in neuroblastoma. Oncol. Rep. 2009, 22:831-835.
28. Chang H., Schimmer A.D. Livin/melanoma inhibitor of apoptosis protein as a potential therapeutic target for the treatment of malignancy. Mol. Cancer Ther. 2007, 6:24-30.
29. Liu B., Han M., Wen J.K., Wang L. Livin/ML-IAP as a new target for cancer treatment. Cancer Lett. 2007, 250:168-176.